Mangrove Partners Ani Pharmaceuticals Inc Transaction History

Mangrove Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $12.8 Million - $21.4 Million	-426,162 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$30.35 - $67.14 $3.02 Million - $6.67 Million	99,384 Added 30.41%	426,162 $17.4 Million
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $10.2 Million - $14.6 Million	-183,174 Reduced 35.92%	326,778 $20.2 Million
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $2.55 Million - $3.37 Million	-39,449 Reduced 7.18%	509,952 $37.2 Million
Q4 2018 Feb 14, 2019	BUY	$41.17 - $56.44 $1.52 Million - $2.09 Million	37,000 Added 7.22%	549,401 $24.7 Million
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $6.11 Million - $8.24 Million	115,478 Added 29.09%	512,401 $29 Million
Q2 2018 Aug 14, 2018	BUY	$56.38 - $68.08 $1.16 Million - $1.4 Million	20,609 Added 5.48%	396,923 $26.5 Million
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $16.4 Million - $19.8 Million	376,314	376,314 $19.8 Million

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $992M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

Stay updated on Mangrove Partners with notifications on news.